Andrew Roughan, Plexal CEO and partner to the UK’s National Cyber Security Centre, advocates for a comprehensive societal approach to cyber security innovation, emphasizing the importance of widespread participation and collaboration.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
